Intelligence · Clinical Pipeline
RIGEL PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at RIGEL PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 3
Quick answer
RIGEL PHARMACEUTICALS has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
GAVRETO ®(pralsetinib) capsules
RIGEL PHARMACEUTICALS INC
Patients with advanced or metastatic solid tumors
1 trial -
Olutasidenib
RIGEL PHARMACEUTICALS INC
AML (Acute Myeloid Leukemia)
1 trial -
imiquimod 5% cream
RIGEL PHARMACEUTICALS INC
Actinic Keratoses
1 trial
Frequently asked questions
How many pipeline programs does RIGEL PHARMACEUTICALS have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs